Presentation

Tuesday

Nov 15, 2022

Say What? Decoding the Regulations Around CBD and Other Cannabinoid Claims

MJBizCon, Las Vegas, NV

The FDA has not been shy about sending enforcement letters even with a lack of regulation and guidance. Operators in the hemp-CBD/cannabinoid marketplace can limit their risk, while still being truthful and not misleading. But what exactly is that magical line businesses cannot cross before getting a Dear John from the FDA? This session will identify high-risk marketing strategies and how to adapt accordingly.


You will learn:

- Recent enforcement trends across the industry

- How to identify high-risk verbiage and example of lower-risk verbiage to communicate the same message

- What is top of mind and what the FDA is looking for when reviewing claims in testimonials, hashtags influences and Tik Tok.

- How to read enforcement actions (i.e. warning letters) and your next steps

- Q&A at the end


Session Date: Tuesday, November 15th, 2022

See the agenda here.